Literature DB >> 31031048

Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies.

Ludovic Trinquart1, Anna Bill-Axelson2, Jennifer R Rider3.   

Abstract

Hazard ratios (HRs) are frequently misinterpreted. We describe an easily estimated complementary measure, the difference in restricted mean survival time (RMST), that requires fewer assumptions than the HR and is more readily interpretable. Reporting RMST-based measures may benefit shared decision-making.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID： 31031048     DOI： 10.1016/j.eururo.2019.04.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  7 in total

1.  Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system.

Authors:  Yan Lu; Aaron W Gehr; Rachel J Meadows; Bassam Ghabach; Latha Neerukonda; Kalyani Narra; Rohit P Ojha
Journal:  BMC Cancer       Date:  2022-05-31       Impact factor: 4.638

2.  Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.

Authors:  Philip W Kantoff; Wassim Abida; Konrad H Stopsack; Subhiksha Nandakumar; Andreas G Wibmer; Samuel Haywood; Emily S Weg; Ethan S Barnett; Chloe J Kim; Emily A Carbone; Samantha E Vasselman; Bastien Nguyen; Melanie A Hullings; Howard I Scher; Michael J Morris; David B Solit; Nikolaus Schultz
Journal:  Clin Cancer Res       Date:  2020-03-27       Impact factor: 12.531

3.  Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials.

Authors:  Isabelle R Weir; Jennifer R Rider; Ludovic Trinquart
Journal:  Pharm Stat       Date:  2021-08-04       Impact factor: 1.894

4.  Statistical Considerations for Sequential Analysis of the Restricted Mean Survival Time for Randomized Clinical Trials.

Authors:  Ying Lu; Lu Tian
Journal:  Stat Biopharm Res       Date:  2020-10-09       Impact factor: 1.452

5.  Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer.

Authors:  Vincent Vinh-Hung; Hilde Van Parijs; Olena Gorobets; Christel Fontaine; Nam P Nguyen; Bhumsuk Keam; Dung Minh Nguyen; Mark De Ridder
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

6.  Psychotropic medication use during pregnancy and gestational age at delivery.

Authors:  Miriam J Haviland; Yael I Nillni; Matthew P Fox; David A Savitz; Elizabeth E Hatch; Kenneth J Rothman; Michele R Hacker; Tanran R Wang; Lauren A Wise
Journal:  Ann Epidemiol       Date:  2020-08-22       Impact factor: 3.797

7.  Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany.

Authors:  Daniel Medenwald; Dirk Vordermark; Christian T Dietzel
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.